Public Release: 

Future of legalized cannabis focus of expert panel discussion in cannabis journal

Mary Ann Liebert, Inc./Genetic Engineering News

IMAGE

IMAGE: Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. view more 

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, September 19, 2017--In the roundtable entitled "Expert Panel on Understanding Cannabis: Medicine, Society, Government," the panelists shared their views on topics ranging from what actions U.S. Attorney General Jeff Sessions might take, the business of growing and selling cannabis, risk of addiction, and whether patients should use cannabis to alleviate cancer pain. The expert Roundtable is published in Cannabis and Cannabinoid Research, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cannabis and Cannabinoid Research website.

Moderator Kyle Kazan, Co-Founder, AP Investment Fund, led a lively and informative discussion on issues related to cannabis at the interface of medicine, society, and government. Bringing to the conversation their broad-ranging knowledge and expertise were panelists Dr. Daniele Piomelli, Professor, University of California, Irvine, School of Medicine; U.S. Rep. Dana Rohrabacher, California's 48th District; and Lori Ajax, Chief, Bureau of Cannabis Control, California Department of Consumer Affairs.

"To fully understand cannabis, we must look at it from the different perspectives of medicine, law, and society at large. This roundtable is meant to be a step in that direction," says Editor-in-Chief Daniele Piomelli, PhD, PharmD, University of California-Irvine, School of Medicine.

###

This roundtable was sponsored by an educational grant from Pascal Labs.

About the Journal

Cannabis and Cannabinoid Research is the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. Led by Editor-in-Chief Daniele Piomelli, PhD, PharmD, the Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioral, social, and epidemiological issues; and ethical, legal, and regulatory controversies. Complete information is available on the Cannabis and Cannabinoid Research website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Medicinal Food, The Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.